The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $131,637,288.00 definitive cost-reimbursement contract to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, to support the NIAID Centers of Excellence for Influenza Research and Response (CEIRR) program. This single-award contract, which does not have a set-aside designation, has a period of performance through September 29, 2026. The CEIRR program aims to advance understanding of influenza emergence, transmission, and control measures through a collaborative network of multidisciplinary research. Penn, as a renowned private research university and academic medical center, leverages its extensive expertise in biomedical sciences and infectious disease research to support NIAID's objectives under this contract.
Generated 1/14/25, 9:23 AM